scholarly journals A Randomized Phase Ii Study of Paclitaxel-Carboplatin-Bevacizumab (Pcb) with or Without Nitroglycerin Patches (Ntg) in Patients (Pts) with Stage Iv Non-Squamous-Non-Small Cell Lung Cancer (Ns-Nsclc)(Nvalt 12), Impact of Circulating Vascular Endothelial Growth Factor (Vegf) Levels

2014 ◽  
Vol 25 ◽  
pp. iv440
Author(s):  
A.C. Dingemans ◽  
H.J.M. Groen ◽  
G. Herder ◽  
E.F. Smit ◽  
S. Burgers ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document